Benjamin Titz

CEO Alkyon Therapeutics

Seminars

Thursday 23rd July 2026
Linking Biodistribution to Efficacy in Radioligand Therapy: Insights & Limitations from Preclinical Dosimetry
Benjamin Titz - Co-Founder and Chief Executive Officer, Alkyon Therapeutics - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA
View all Speakers
View Event Brochure